JSE slips marginally as global risks persist

The JSE was slightly weaker on Monday morning, with its global peers mixed as prospects for a pick up in economic growth contended with concerns over a number of risks.

US equities climbed on Friday after news that a new oral antiviral treatment for Covid-19 from Merck — a US multinational pharmaceutical company — reduced the risk of hospitalisation or death by 50% for patients with mild or moderate cases. The company disclosed plans to seek emergency authorisation for the treatment…

Source: businesslive.co.za